Novel sulfur-containing ERα modulators (compounds 4 and 5) as potential breast cancer therapeutic drug candidates were designed and synthesized based upon the hydrophobic feedback approach for the simple bisphenols 1–3 developed in our previous studies. The gene discussed is ESR1; the disease is breast carcinoma.